Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Adalimumab
Related studies linked through entity extraction aliases.
Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
- Status
- WITHDRAWN
- Phase
- N/A
Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Adalimumab for Inflammatory Osteoarthritis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Adalimumab in Adult Japanese Subjects With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE2